PERP, a p53 proapoptotic target, mediates apoptotic cell death in renal ischemia

American Journal of Physiology - Renal Physiology

Volumn 296, Issue 4, 2009, Pages

  Singaravelu, Kurinji ^a   Devalaraja Narashimha, Kishor ^a   Lastovica, Brynn ^b   Padanilam, Babu J ^a,b,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Acute renal failure; AIF; Caspase; Mitochondria

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE 9; CYTOCHROME C; MESSENGER RNA; PROTEIN P53; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE OVEREXPRESSION; HYPOXIA; KIDNEY ISCHEMIA; KIDNEY PERFUSION; KIDNEY PROXIMAL TUBULE; MALE; MITOCHONDRIAL PERMEABILITY; MOUSE; NONHUMAN; PERP GENE; PRIORITY JOURNAL; REPERFUSION INJURY; TUMOR SUPPRESSOR GENE;

EID: 65949087224     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90438.2008     Document Type: Article

References (50)

1. Attardi LD, DePinho RA. Conquering the complexity of p53. Nat Genet 36: 7-8, 2004.
2. Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, Lowe SW, Jacks T. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev 14: 704-718, 2000. (Pubitemid 30176824)
3. Baptiste N, Prives C. p53 in the cytoplasm: a question of overkill? Cell 116: 487-489, 2004. (Pubitemid 38264426)
4. Basile DP, Liapis H, Hammerman MR. Expression of bcl-2 and bax in regenerating rat renal tubules following ischemic injury. Am J Physiol Renal Physiol 272: F640-F647, 1997. (Pubitemid 27382213)
5. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309: 1732-1735, 2005. (Pubitemid 41285944)
6. Cummings BS, Schnellmann RG. Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther 302: 8-17, 2002.
7. Daemen MA, de Vries B, Buurman WA. Apoptosis and inflammation in renal reperfusion injury. Transplantation 73: 1693-1700, 2002.
8. Daemen MA, van 't Veer C, Denecker G, Heemskerk VH, Wolfs TG, Clauss M, Vandenabeele P, Buurman WA. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104:541-549, 1999.
9. Dagher PC. Apoptosis in ischemic renal injury: roles of GTP depletion and p53. Kidney Int 66: 506-509, 2004.
10. Devalaraja-Narashimha K, Padanilam BJ. PERP, a mediator of p53-dependent apoptosis, is highly induced and translocated to the nucleus following ischemic renal injury (Abstract). J Am Soc Nephrol 15: 712A, 2004.
11. Fortin A, MacLaurin JG, Arbour N, Cregan SP, Kushwaha N, Callaghan SM, Park DS, Albert PR, Slack RS. The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1. J Biol Chem 279: 28706-28714, 2004. (Pubitemid 38900155)
12. Fraker PJ, King LE, Lill-Elghanian D, Telford WG. Quantification of apoptotic events in pure and heterogeneous populations of cells using the flow cytometer. Methods Cell Biol 46: 57-76, 1995.
13. Gravestein LA, Blom B, Nolten LA, de Vries E, van der Horst G, Ossendorp F, Borst J, Loenen WA. Cloning and expression of murine CD27: comparison with 4-1BB, another lymphocyte-specific member of the nerve growth factor receptor family. Eur J Immunol 23: 943-950, 1993. (Pubitemid 23101083)
14. Hamar P, Song E, Kokeny G, Chen A, Ouyang N, Lieberman J. Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. PNAS 101: 14883-14888, 2004. (Pubitemid 39410769)
15. Ihrie RA, Attardi LD. Perp-etrating p53-dependent apoptosis. Cell Cycle 3: 267-269, 2004.
16. Ihrie RA, Bronson RT, Attardi LD. Adult mice lacking the p53//p63 target gene Perp are not predisposed to spontaneous tumorigenesis but display features of ectodermal dysplasia syndromes. Cell Death Differ 13:1614-1618, 2006.
17. Ihrie RA, Reczek E, Horner JS, Khachatrian L, Sage J, Jacks T, Attardi LD. Perp is a mediator of p53-dependent apoptosis in diverse cell types. Curr Biol 13: 1985-1990, 2003.
18. Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J, MacLean KH, Han J, Chittenden T, Ihle JN, McKinnon PJ, Cleveland JL, Zambetti GP. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4: 321-328, 2003. (Pubitemid 37329796)
19. Jiang M, Dong Z. Regulation and pathological role of p53 in cisplatin nephrotoxicity. J Pharmacol Exp Ther 327: 300-307, 2008.
20. Jiang M, Yi X, Hsu S, Wang CY, Dong Z. Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity. Am J Physiol Renal Physiol 287: F1140-F1147, 2004. (Pubitemid 39507222)
21. Kaushal GP, Singh AB, Shah SV. Identification of gene family of caspases in rat kidney and altered expression in ischemia-reperfusion injury. Am J Physiol Renal Physiol 274: F587-F595, 1998.
22. Kelly K, Plotkin Z, Dagher P. Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury. J Clin Invest 108: 1291-1298, 2001. (Pubitemid 33107756)
23. Kelly KJ, Plotkin Z, Vulgamott SL, Dagher PC. P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor. J Am Soc Nephrol 14: 128-138, 2003. (Pubitemid 36026304)
24. Lorz C, Ortiz A, Justo P, Gonzalez-Cuadrado S, Duque N, Gomez-Guerrero C, Egido J. Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J Am Soc Nephrol 11:1266-1277, 2000. (Pubitemid 30416223)
25. Marques MR, Horner JS, Ihrie RA, Bronson RT, Attardi LD. Mice lacking the p53/p63 target gene Perp are resistant to papilloma development. Cancer Res 65: 6551-6556, 2005.
26. Marques MR, Ihrie RA, Horner JS, Attardi LD. The requirement for perp in postnatal viability and epithelial integrity reflects an intrinsic role in stratified epithelia. J Invest Dermatol 126: 69-73, 2006.
27. Martinou JC, Green DR. Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 12: 63-67, 2001.
28. Menendez D, Inga A, Resnick MA. The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes. Mol Cell Biol 26:2297-2308, 2006. (Pubitemid 43346929)
29. Mills AA. p53: link to the past, bridge to the future Genes Dev 19: 2091-2099, 2005.
30. Nowak M, Koster C, Hammerschmidt M. Perp is required for tissue-specific cell survival during zebrafish development. Cell Death Differ 12:52-64, 2005. (Pubitemid 40090028)
31. Padanilam B, Lewington A, Hammerman M. Expression of CD27 and ischemia/reperfusion-induced expression of its ligand Siva in rat kidneys. Kidney Int 6 54: 1967-1975, 1998. (Pubitemid 28533624)
32. Padanilam BJ. Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol 284: F608-F627, 2003.
33. 2 induced necrotic cell death. Am J Nephrol 23: 380-389, 2003.
34. Prasad KV, Ao Z, Yoon Y, Wu MX, Rizk M, Jacquot S, Schlossman SF. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc Natl Acad Sci USA 94: 6346-6351, 1997. (Pubitemid 27270687)
35. Price PM, Safirstein RL, Megyesi J. Protection of renal cells from cisplatin toxicity by cell cycle inhibitors. Am J Physiol Renal Physiol 286: F378-F384, 2004. (Pubitemid 38141683)
36. Reczek EE, Flores ER, Tsay AS, Attardi LD, Jacks T. Multiple response elements and differential p53 binding control perp expression during apoptosis. Mol Cancer Res 1: 1048-1057, 2003. (Pubitemid 38044980)
37. Riccardi C, Nicoletti I. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 1: 1458-1461, 2006.
38. Saikumar P, Venkatachalam MA. Role of apoptosis in hypoxic/ischemic damage in the kidney. Semin Nephrol 23: 511-521, 2003. (Pubitemid 38030085)
39. Singaravelu K, Padanilam BJ. The p53 pro-apoptotic target, PERP, induces mitochondrial permeability and apoptosis in hypoxic renal cells (Abstract). FASEB J 22: 730.11, 2008.
40. Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, Steele GD Jr, Chen LB. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci USA 88: 3671-3675, 1991. (Pubitemid 21916685)
41. Telford WG, King LE, Fraker PJ. Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. J Immunol Methods 172: 1-16, 1994.
42. Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, Ausserlechner MJ, Adams JM, Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302: 1036-1038, 2003. (Pubitemid 37386194)
43. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 408: 307-310, 2000.
44. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2: 594-604, 2002. (Pubitemid 37328926)
45. Wei Q, Dong G, Yang T, Megyesi J, Price PM, Dong Z. Activation and involvement of p53 in cisplatin-induced nephrotoxicity. Am J Physiol Renal Physiol 293: F1282-F1291, 2007. (Pubitemid 47583963)
46. Xiao T, Choudhary S, Zhang W, Ansari NH, Salahudeen A. Possible involvement of oxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells. J Toxicol Environ Health 66: 469-479, 2003. (Pubitemid 36269798)
47. Xue L, Chu F, Cheng Y, Sun X, Borthakur A, Ramarao M, Pandey P, Wu M, Schlossman SF, Prasad KVS. Siva-1 binds to and inhibits BCL-XL-mediated protection against UV radiation-induced apoptosis. PNAS 99: 6925-6930, 2002. (Pubitemid 34526234)
48. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. PNAS 100: 1931-1936, 2003. (Pubitemid 36254551)
49. Yu J, Zhang L. No PUMA, no death: implications for p53-dependent apoptosis. Cancer Cell 4: 248-249, 2003. (Pubitemid 37329788)
50. Zheng J, Devalaraja-Narashimha K, Singaravelu K, Padanilam BJ. Poly(ADP-ribose) polymerase-1 gene ablation protects mice from ischemic renal injury. Am J Physiol Renal Physiol 288: F387-F398, 2005. (Pubitemid 40105398)